Explaining the FDA 1271 Regs Using Common Orthobiologics
Dr Centeno discusses the FDAs 1271 regulations by classifying common orthbiologics into either a medical procedure, 361 tissue, or 351 drug.
Free Regenexx® Webinar
Join Chris Centeno, M.D., founder of Regenexx, to learn about how Regenexx procedures can treat your orthopedic injury.
View WebinarFind a Regenexx Provider
Regenexx is a world-wide network of specially trained physicians providing the world's most advanced, research-driven, regenerative interventional orthopedic procedures in North America, Europe, the Middle East, Asia and Australia.